Answer
Daratumumab (Darzalex) infusion is not recommended for children under 18 years because efficacy has not been established.
Sources for this answer
- DARZALEX 20 mg/mL concentrate for solution for infusionJanssen-Cilag Ltd (a Johnson & Johnson Company) · emc · SmPC §4.2 Posology and method of administration · Version 34Document updated
Sources checked